Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
14 March 2016 |
Main ID: |
NCT02591992 |
Date of registration:
|
27/10/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Computed Tomography as the First-Choice Diagnostics in High Pre-Test Probability of Coronary Artery Disease
CAT-CAD |
Scientific title:
|
Coronary Artery Computed Tomography as the First-Choice Imaging Diagnostics in Patients With High Pre-Test Probability of Coronary Artery Disease |
Date of first enrolment:
|
October 2015 |
Target sample size:
|
120 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02591992 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Poland
| | | | | | | |
Contacts
|
Name:
|
Piotr N Rudzinski, M.D. |
Address:
|
|
Telephone:
|
+48608499737 |
Email:
|
piotr.rudzinski@ikard.pl |
Affiliation:
|
|
|
Name:
|
Mariusz Kruk, Prof. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Institute of Cardiology, Warsaw, Poland |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Age >18 years
2. Patients providing written informed consent
3. Indications for elective invasive coronary angiography defined by European Society of
Cardiology as:
- Left ventricle ejection fraction <50% and typical angina symptoms,
- Probability of coronary artery disease due to criteria of age, sex and symptoms
>85%, or
- Probability of coronary artery disease due to criteria of age, sex and symptoms
50-85% with positive or moderate cardiac stress test.
Exclusion Criteria:
1. No Consent to the study
2. Acute coronary syndrome
3. Recurrence of typical angina symptoms 1 year after the last percutaneous coronary
revascularization,
4. Contraindications to invasive coronary angiography
5. GFR <60 ml/min/1.73m2
6. Significant arrhythmia
7. BMI >35 kg/m2
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Coronary Artery Disease
|
Intervention(s)
|
Other: Cardiac CT as the first diagnostic modality in suspected CAD
|
Other: Invasive coronary angiography as indicated by the guidelines
|
Primary Outcome(s)
|
The proportion of "avoidable" invasive diagnostic procedures (coronary angiographies not followed by an intervention) in the arm: A. Angio-CT versus B. Classic diagnostics (superiority)
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
The average number of invasive procedures (coronary angiography/PCI) in the arm: A. Angio - CT versus B. Classic diagnostics (superiority)
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization, hospitalization for cardiovascular reason, stroke
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Secondary Outcome(s)
|
Average consumption of resources (comparison of coronary artery disease diagnosis and treatment costs in accordance to National Health Service and Institute of Cardiology price lists.
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Average time to complete diagnostic and therapeutic cycle (from the first examination of the coronary arteries to termination or disqualification from the surgical treatment).
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Number of angioplasty procedures performed in accordance with ESC recommendations where the treatment planned on the basis of CT angiography by an interventional cardiologist is not treated ad-hoc.
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Average number of therapeutic procedures (PCI/CABG).
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Time to occurrence of composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization (including restenosis), urgent hospitalization for cardiovascular reason, stroke
[Time Frame: up to 36 months (through study completion)]
|
Average number of days of hospitalization required to complete the diagnostic and therapeutic cycle.
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
composite outcome: number of serious adverse events during diagnosis and treatment of coronary artery disease
[Time Frame: up to 36 months (through study completion)]
|
Time to occurrence of composite outcome of: myocardial infarction, death, acute coronary syndrome, unplanned coronary revascularization (including restenosis), urgent hospitalization for cardiovascular reason, stroke
[Time Frame: up to 3 months (until the last diagnostic/therapeutic procedure; it is assumed it will be completed within 3 months of the participants study entry).]
|
Secondary ID(s)
|
2.13/III/15
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|